News & Events
News & Events
March 14, 2019
C-Path, FNIH Announce Clinical Development User’s Guide for Kidney Safety BiomarkersTUCSON, Ariz., March 14, 2019 — The Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PSTC) today announced availability of the User’s Guide: Kidney Safety Composite Measure Biomarker for Use in Clinical Development. Authored by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Kidney Safety Biomarker Project Team and PSTC’s...
- March 13, 2019 - March 16, 2019
February 27, 2019
C-Path and FARA Launch Friedreich’s Ataxia Integrated Clinical Database to Advance the Development of Treatments for FATUCSON, Ariz. and DOWNINGTOWN, Penn., February 27, 2019 — Critical Path Institute’s (C-Path) Data Collaboration Center (DCC) and the Friedreich’s Ataxia Research Alliance (FARA) today announced the launch of the Friedreich’s Ataxia Integrated Clinical Database (FAICD). The new platform will enable collaborative research and data sharing to support the understanding of natural history, potential biomarkers...
February 23, 2019
Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies
Adedeji, Adeyemi O., Tony Pourmohamad, Yafei Chen, Jennifer Burkey, Catherine J. Betts, Susan J. Bickerton, Manisha Sonee, and James E. McDuffie. “Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies.” International Journal of Toxicology 38, no. 1 (February 2019): 12–22.
February 16, 2019
Recommendations for the Design of Therapeutic Trials for Neonatal Seizures
Janet S. Soul, Ronit Pressler, Marilee Allen, Geraldine Boylan, Heike Rabe, Ron Portman, Pollyanna Hardy, Sarah Zohar, Klaus Romero, Brian Tseng, Varsha Bhatt-Mehta, Cecil Hahn, Scott Denne, Stephane Auvin, Alexander Vinks, John Lantos, Neil Marlow and Jonathan M. Davis for the International Neonatal Consortium.